What are the major opportunities in the end stage renal disease (ESRD) drug market? What are the strategies for the end stage renal disease (ESRD) drug market?

For detailed insights on the major opportunities and strategies in the end stage renal disease (ESRD) drug market, Read More

How does the end stage renal disease (ESRD) drug market relate to the overall economy and other similar markets?

For detailed insights on end stage renal disease (ESRD) drug market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the end stage renal disease (ESRD) drug market growth? SWOT analysis of the end stage renal disease (ESRD) drug market.

For detailed insights on the key dynamics influencing the end stage renal disease (ESRD) drug market growth and SWOT analysis of the end stage renal disease (ESRD) drug industry, Read More

End Stage Renal Disease (ESRD) Drug Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

End Stage Renal Disease (ESRD) Drug Market Report 2026

Name: End Stage Renal Disease (ESRD) Drug Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product Type (Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Other Products), By Indication (End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkaliemia), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

End Stage Renal Disease (ESRD) Drug Market Overview

• End Stage Renal Disease (ESRD) Drug market size has reached to $148.55 billion in 2025

• Expected to grow to $304.07 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%

• Growth Driver: The Interconnection Of Obesity And Diabetes In Fueling End-Stage Renal Disease (ESRD) Drug Market Growth

• Market Trend: Increasing Focus On Product Approvals To Provide Reliable Services To Their Customers

• North America was the largest region in 2025.

What Is Covered Under End Stage Renal Disease (ESRD) Drug Market?

End stage renal disease (ESRD) drug is a drug used to treat a medical illness in which a person's kidneys stop working permanently, requiring a kidney transplant or a regular regimen of long-term dialysis to protect life. It is crucial in treating and preventing secondary problems in individuals with chronic renal disease (CKD).

The main end stage renal disease (ESRD) drugs are calcimimetics, vitamin D, sterols, potassium binders, calcium-based phosphate binders, and others. Calcimimetics can be used to reduce PTH in kidney disease stage 5D, depending on serum calcium and phosphorus levels. The various indications include end stage renal disease (ESRD) induced hyperparathyroidism, end stage renal disease (ESRD) induced hyperphosphatemia, and end stage renal disease (ESRD) induced hyperkaliemia. It is distributed by hospital pharmacy, online pharmacy, and retail pharmacy to be used by hospitals, homecare, specialty clinics, and other end users.

End Stage Renal Disease (ESRD) Drug Market Global Report 2026 Market Report bar graph

What Is The End Stage Renal Disease (ESRD) Drug Market Size and Share 2026?

The end stage renal disease (esrd) drug market size has grown rapidly in recent years. It will grow from $148.55 billion in 2025 to $171.12 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to growing prevalence of ckd, increasing awareness of esrd, rise in dialysis centers, advancements in renal therapeutics, government healthcare initiatives.

What Is The End Stage Renal Disease (ESRD) Drug Market Growth Forecast?

The end stage renal disease (esrd) drug market size is expected to see rapid growth in the next few years. It will grow to $304.07 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to development of precision medicine, expansion of homecare dialysis, integration of ai in patient monitoring, rising investments in esrd r&d, growing adoption of combination therapies. Major trends in the forecast period include personalized esrd drug therapy, home-based dialysis solutions, telemedicine integration in ckd management, advanced drug formulations for secondary complications, increasing adoption of combination therapies.

Book your 30 minutes free consultation with our research experts

Global End Stage Renal Disease (ESRD) Drug Market Segmentation

1) By Product Type: Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Other Products

2) By Indication: End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkaliemia

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Calcimimetics: Cinacalcet, Etelcalcetide

2) By Vitamin D: Calcitriol, Doxercalciferol, Paricalcitol

3) By Sterols: Ergocalciferol, Cholecalciferol

4) By Potassium Binders: Sodium Polystyrene Sulfonate, Patiromer, Sodium Zirconium Cyclosilicate

5) By Calcium-Based Phosphate Binders: Calcium Acetate, Calcium Carbonate

6) By Other Products: Iron Supplements, Erythropoiesis-Stimulating Agents

What Is The Driver Of The End Stage Renal Disease (ESRD) Drug Market?

Rising cases of obesity and diabetes are expected to propel the growth of the end-stage renal disease (ESRD) drug market going forward. Obesity is described as abnormal or excessive fat buildup that poses a health concern. In contrast, diabetes is a chronic condition that happens when the pancreas does not create enough insulin or when the body cannot utilize the insulin produced efficiently. In patients with renal disease, managing fluid and electrolyte levels, blood pressure, and waste product elimination through dialysis can improve general health and well-being, which may lead to weight reduction and improved blood sugar control. For instance, in 2023, the World Obesity Federation, a non profit membership organization, projects that by 2035 the economic cost of overweight and obesity will reach US$ 4.32 trillion annually, equivalent to nearly 3% of globaFor instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rising cases of obesity and diabetes will drive the market for end-stage renal disease (ESRD) drugs.

Key Players In The Global End Stage Renal Disease (ESRD) Drug Market

Major companies operating in the end stage renal disease (esrd) drug market are Pfizer Inc., AstraZeneca plc, Sanofi SA, Astellas Pharma Inc., Novartis AG, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd., Kissei Pharmaceutical Co. Ltd., Baxter International Inc., AbbVie Inc., Amgen Inc., Akebia Drugs Inc., Bayer AG, Bristol-Myers Squibb Company, B. Braun SE, Asahi Kasei Medical Co. Ltd., Nikkiso Co. Ltd., Abbott Laboratories, Merck Co. & KGaA

Global End Stage Renal Disease (ESRD) Drug Market Trends and Insights

Major companies operating in the end-stage renal disease (ESRD) drug market are focusing on product approvals such as Jardiance to drive revenues in their market. Empagliflozin is a drug intended to help persons with type 2 diabetes and to lower the chance of cardiovascular issues in persons with type 2 diabetes who have heart failure or cardiovascular disease. For instance, in September 2023, Boehringer Ingelheim Pharmaceuticals Inc. a US-based pharmaceutical company received FDA approval for Jardiance. Jardiance has been approved for a number of indications, such as lowering the risk of end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression, as well as lowering the risk of sustained decline in estimated glomerular filtration rate (eGFR) in adults with heart failure. Jardiance is a sodium-glucose cotransporter 2 (SGLT2) inhibitor and is contraindicated in patients with type 1 diabetes and those with an eGFR less than 20 ml/min/1.73 m.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The End Stage Renal Disease (ESRD) Drug Market?

In May 2024, Vertex Pharmaceuticals, a U.S.-based biotechnology company developing treatments for genetic diseases and immunology, acquired Alpine Immune Sciences for an undisclosed amount. With this acquisition, Vertex aimed to expand its renal disease portfolio by securing povetacicept, Alpine’s lead asset targeting IgA nephropathy (IgAN), a chronic autoimmune kidney disease that can progress to end stage renal disease, and to integrate Alpine’s protein-engineering and immunotherapy capabilities. Alpine Immune Sciences is a U.S.-based clinical-stage biotech focused on engineered immunotherapies, with its dual BAFF/APRIL antagonist povetacicept poised to enter Phase 3 development for IgAN.

Regional Insights

North America was the largest region in the end stage renal disease (ESRD) drug market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the End Stage Renal Disease (ESRD) Drug Market?

The end-stage renal disease (ESRD) drug market consists of sales of cinacalcet hcl, diuretics, sevelamer, epoetin alfa, and over-the-counter drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the End Stage Renal Disease (ESRD) Drug Market Report 2026?

The end stage renal disease (esrd) drug market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the end stage renal disease (esrd) drug industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

End Stage Renal Disease (ESRD) Drug Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$171.12 billion
Revenue Forecast In 2035	$304.07 billion
Growth Rate	CAGR of 15.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product Type, Indication, Distribution Channel, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., AstraZeneca plc, Sanofi SA, Astellas Pharma Inc., Novartis AG, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd., Kissei Pharmaceutical Co. Ltd., Baxter International Inc., AbbVie Inc., Amgen Inc., Ake
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. End Stage Renal Disease (ESRD) Drug Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global End Stage Renal Disease (ESRD) Drug Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. End Stage Renal Disease (ESRD) Drug Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global End Stage Renal Disease (ESRD) Drug Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Personalized Esrd Drug Therapy

4.2.2 Home-Based Dialysis Solutions

4.2.3 Telemedicine Integration In Ckd Management

4.2.4 Advanced Drug Formulations For Secondary Complications

4.2.5 Increasing Adoption Of Combination Therapies

5. End Stage Renal Disease (ESRD) Drug Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Homecare

5.3 Specialty Clinics

5.4 Renal Care Centers

5.5 Pharmacies

6. End Stage Renal Disease (ESRD) Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global End Stage Renal Disease (ESRD) Drug Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global End Stage Renal Disease (ESRD) Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global End Stage Renal Disease (ESRD) Drug Market Size, Comparisons And Growth Rate Analysis

7.3. Global End Stage Renal Disease (ESRD) Drug Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global End Stage Renal Disease (ESRD) Drug Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global End Stage Renal Disease (ESRD) Drug Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. End Stage Renal Disease (ESRD) Drug Market Segmentation

9.1. Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Other Products

9.2. Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkaliemia

9.3. Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

9.4. Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Specialty Clinics, Other End Users

9.5. Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Calcimimetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cinacalcet, Etelcalcetide

9.6. Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Vitamin D, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Calcitriol, Doxercalciferol, Paricalcitol

9.7. Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Sterols, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ergocalciferol, Cholecalciferol

9.8. Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Potassium Binders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sodium Polystyrene Sulfonate, Patiromer, Sodium Zirconium Cyclosilicate

9.9. Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Calcium-Based Phosphate Binders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Calcium Acetate, Calcium Carbonate

9.10. Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Iron Supplements, Erythropoiesis-Stimulating Agents

10. End Stage Renal Disease (ESRD) Drug Market Regional And Country Analysis

10.1. Global End Stage Renal Disease (ESRD) Drug Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global End Stage Renal Disease (ESRD) Drug Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific End Stage Renal Disease (ESRD) Drug Market

11.1. Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China End Stage Renal Disease (ESRD) Drug Market

12.1. China End Stage Renal Disease (ESRD) Drug Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India End Stage Renal Disease (ESRD) Drug Market

13.1. India End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan End Stage Renal Disease (ESRD) Drug Market

14.1. Japan End Stage Renal Disease (ESRD) Drug Market Overview

14.2. Japan End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia End Stage Renal Disease (ESRD) Drug Market

15.1. Australia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia End Stage Renal Disease (ESRD) Drug Market

16.1. Indonesia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea End Stage Renal Disease (ESRD) Drug Market

17.1. South Korea End Stage Renal Disease (ESRD) Drug Market Overview

17.2. South Korea End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan End Stage Renal Disease (ESRD) Drug Market

18.1. Taiwan End Stage Renal Disease (ESRD) Drug Market Overview

18.2. Taiwan End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia End Stage Renal Disease (ESRD) Drug Market

19.1. South East Asia End Stage Renal Disease (ESRD) Drug Market Overview

19.2. South East Asia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe End Stage Renal Disease (ESRD) Drug Market

20.1. Western Europe End Stage Renal Disease (ESRD) Drug Market Overview

20.2. Western Europe End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK End Stage Renal Disease (ESRD) Drug Market

21.1. UK End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany End Stage Renal Disease (ESRD) Drug Market

22.1. Germany End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France End Stage Renal Disease (ESRD) Drug Market

23.1. France End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy End Stage Renal Disease (ESRD) Drug Market

24.1. Italy End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain End Stage Renal Disease (ESRD) Drug Market

25.1. Spain End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe End Stage Renal Disease (ESRD) Drug Market

26.1. Eastern Europe End Stage Renal Disease (ESRD) Drug Market Overview

26.2. Eastern Europe End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia End Stage Renal Disease (ESRD) Drug Market

27.1. Russia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America End Stage Renal Disease (ESRD) Drug Market

28.1. North America End Stage Renal Disease (ESRD) Drug Market Overview

28.2. North America End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA End Stage Renal Disease (ESRD) Drug Market

29.1. USA End Stage Renal Disease (ESRD) Drug Market Overview

29.2. USA End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada End Stage Renal Disease (ESRD) Drug Market

30.1. Canada End Stage Renal Disease (ESRD) Drug Market Overview

30.2. Canada End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America End Stage Renal Disease (ESRD) Drug Market

31.1. South America End Stage Renal Disease (ESRD) Drug Market Overview

31.2. South America End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil End Stage Renal Disease (ESRD) Drug Market

32.1. Brazil End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East End Stage Renal Disease (ESRD) Drug Market

33.1. Middle East End Stage Renal Disease (ESRD) Drug Market Overview

33.2. Middle East End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa End Stage Renal Disease (ESRD) Drug Market

34.1. Africa End Stage Renal Disease (ESRD) Drug Market Overview

34.2. Africa End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. End Stage Renal Disease (ESRD) Drug Market Regulatory and Investment Landscape

36. End Stage Renal Disease (ESRD) Drug Market Competitive Landscape And Company Profiles

36.1. End Stage Renal Disease (ESRD) Drug Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. End Stage Renal Disease (ESRD) Drug Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. End Stage Renal Disease (ESRD) Drug Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. End Stage Renal Disease (ESRD) Drug Market Other Major And Innovative Companies

Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd., Kissei Pharmaceutical Co. Ltd., Baxter International Inc., AbbVie Inc., Amgen Inc., Akebia Drugs Inc., Bayer AG, Bristol-Myers Squibb Company, B. Braun SE, Asahi Kasei Medical Co. Ltd., Nikkiso Co. Ltd., Abbott Laboratories, Merck Co. & KGaA

38. Global End Stage Renal Disease (ESRD) Drug Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The End Stage Renal Disease (ESRD) Drug Market

40. End Stage Renal Disease (ESRD) Drug Market High Potential Countries, Segments and Strategies

40.1 End Stage Renal Disease (ESRD) Drug Market In 2030 - Countries Offering Most New Opportunities

40.2 End Stage Renal Disease (ESRD) Drug Market In 2030 - Segments Offering Most New Opportunities

40.3 End Stage Renal Disease (ESRD) Drug Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global End Stage Renal Disease (ESRD) Drug Market, Overview Of Key Products - Product Examples

Table 2: Global End Stage Renal Disease (ESRD) Drug Market Attractiveness, Factor-Wise Evaluation

Table 3: Global End Stage Renal Disease (ESRD) Drug Market, Supply Chain Analysis

Table 4: Global End Stage Renal Disease (ESRD) Drug Market, Major Raw Material Providers

Table 5: Global End Stage Renal Disease (ESRD) Drug Market, Major Resource Providers

Table 6: Global End Stage Renal Disease (ESRD) Drug Market, Major Manufacturers (Suppliers)

Table 7: Global End Stage Renal Disease (ESRD) Drug Market, Major Distributors And Channel Partners

Table 8: Global End Stage Renal Disease (ESRD) Drug Market, Key Technologies & Future Trends

Table 9: Global End Stage Renal Disease (ESRD) Drug Market, Major Trends

Table 10: Global End Stage Renal Disease (ESRD) Drug Market, Major End Users

Table 11: Global End Stage Renal Disease (ESRD) Drug Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global End Stage Renal Disease (ESRD) Drug Historic Market Growth, 2020-2025, $ Billion

Table 13: Global End Stage Renal Disease (ESRD) Drug Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global End Stage Renal Disease (ESRD) Drug Market - TAM, US$ Billion, 2025

Table 15: Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Calcimimetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Vitamin D, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Sterols, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Potassium Binders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Calcium-Based Phosphate Binders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global End Stage Renal Disease (ESRD) Drug Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global End Stage Renal Disease (ESRD) Drug Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Global End Stage Renal Disease (ESRD) Drug Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 100: Global End Stage Renal Disease (ESRD) Drug Market - Company Scoring Matrix

Table 101: Pfizer Inc. Financial Performance

Table 102: AstraZeneca plc Financial Performance

Table 103: Sanofi SA Financial Performance

Table 104: Astellas Pharma Inc. Financial Performance

Table 105: Novartis AG Financial Performance

Table 106: Global End Stage Renal Disease (ESRD) Drug Market, Competitive Benchmarking (In USD Billions)

Table 107: Global End Stage Renal Disease (ESRD) Drug Market, Competitive Dashboard

Table 108: Global End Stage Renal Disease (ESRD) Drug Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 109: Global, End Stage Renal Disease (ESRD) Drug Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 110: Global, End Stage Renal Disease (ESRD) Drug Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Table 111: Global, End Stage Renal Disease (ESRD) Drug Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global End Stage Renal Disease (ESRD) Drug Market, Overview Of Key Products - Product Examples

Figure 2: Global End Stage Renal Disease (ESRD) Drug Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global End Stage Renal Disease (ESRD) Drug Market, Supply Chain Analysis

Figure 4: Global End Stage Renal Disease (ESRD) Drug Market, Major Raw Material Providers

Figure 5: Global End Stage Renal Disease (ESRD) Drug Market, Major Resource Providers

Figure 6: Global End Stage Renal Disease (ESRD) Drug Market, Major Manufacturers (Suppliers)

Figure 7: Global End Stage Renal Disease (ESRD) Drug Market, Major Distributors And Channel Partners

Figure 8: Global End Stage Renal Disease (ESRD) Drug Market, Key Technologies & Future Trends

Figure 9: Global End Stage Renal Disease (ESRD) Drug Market, Major Trends

Figure 10: Global End Stage Renal Disease (ESRD) Drug Market, Major End Users

Figure 11: Global End Stage Renal Disease (ESRD) Drug Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global End Stage Renal Disease (ESRD) Drug Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global End Stage Renal Disease (ESRD) Drug Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global End Stage Renal Disease (ESRD) Drug Market - TAM, US$ Billion, 2025

Figure 15: Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Calcimimetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Vitamin D, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Sterols, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Potassium Binders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Calcium-Based Phosphate Binders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global End Stage Renal Disease (ESRD) Drug Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global End Stage Renal Disease (ESRD) Drug Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global End Stage Renal Disease (ESRD) Drug Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Global End Stage Renal Disease (ESRD) Drug Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 100: Global End Stage Renal Disease (ESRD) Drug Market - Company Scoring Matrix

Figure 101: Pfizer Inc. Financial Performance

Figure 102: AstraZeneca plc Financial Performance

Figure 103: Sanofi SA Financial Performance

Figure 104: Astellas Pharma Inc. Financial Performance

Figure 105: Novartis AG Financial Performance

Figure 106: Global End Stage Renal Disease (ESRD) Drug Market, Competitive Benchmarking (In USD Billions)

Figure 107: Global End Stage Renal Disease (ESRD) Drug Market, Competitive Dashboard

Figure 108: Global End Stage Renal Disease (ESRD) Drug Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 109: Global, End Stage Renal Disease (ESRD) Drug Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 110: Global, End Stage Renal Disease (ESRD) Drug Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Figure 111: Global, End Stage Renal Disease (ESRD) Drug Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Late Stage Chronic Kidney Disease Drugs Market Report 2026 - Global Outlook – By Product Type (Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders), By Indication Type (Late Stage Chroni...

Kidney Cancer Drugs Market Report 2026 - Global Outlook – By Cancer Type (Renal Cell Carcinoma (RCC), Transitional Cell Carcinoma (TCC) Or Urothelial Cell Carcinoma (UCC)), By Product (Nexavar (Sorafenib), Sutent (Suniti...

Continuous Renal Replacement Therapy Market Report 2026 - Global Outlook – By Product (System, Consumables), By Therapy (Renal, Non-Renal), By Modality (Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemo...

Kidney Disease Market Report 2026 - Global Outlook – By Treatment (Medication, Dialysis, Surgery, Other Treatments), By Indication (Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications)...

Nephrology Drugs Market Report 2026 - Global Outlook – By Drugs (Antihypertensive Agents, Erythropoiesis-Stimulating Agents, Diuretics, ACE Inhibitors, Antidiabetic Agents, Other Drugs), By Route Of Administration (Oral,...

Continuous Renal Replacement Therapy Machine Market Report 2026 - Global Outlook – By Type (Mobile, Fixed), By Modality (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Ven...

Kidney Dialysis Market Report 2026 - Global Outlook – By Type (Hemodialysis, Peritoneal Dialysis), By Product And Service (Equipment, Consumables, Dialysis Drugs, Services), By End-User (Home Care, Dialysis Centers And H...

Frequently Asked Questions

How big is the End Stage Renal Disease (ESRD) Drug Market?

The End Stage Renal Disease (ESRD) Drug market was valued at $148.55 billion in 2025, increased to $171.12 billion in 2026, and is projected to reach $304.07 billion by 2030.

What is the End Stage Renal Disease (ESRD) Drug market growth?

The global End Stage Renal Disease (ESRD) Drug market is expected to grow at a CAGR of 15.5% from 2026 to 2035 to reach $304.07 billion by 2035.

Who are the key players in End Stage Renal Disease (ESRD) Drug market?

Some Key Players in the End Stage Renal Disease (ESRD) Drug market Include, Pfizer Inc., AstraZeneca plc, Sanofi SA, Astellas Pharma Inc., Novartis AG, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd., Kissei Pharmaceutical Co. Ltd., Baxter International Inc., AbbVie Inc., Amgen Inc., Akebia Drugs Inc., Bayer AG, Bristol-Myers Squibb Company, B. Braun SE, Asahi Kasei Medical Co. Ltd., Nikkiso Co. Ltd., Abbott Laboratories, Merck Co. & KGaA .

What is the anticipated growth trend for the End Stage Renal Disease (ESRD) Drug market?

Major trend in this market includes: Increasing Focus On Product Approvals To Provide Reliable Services To Their Customers. For further insights on this market. request a sample here

Which region has the most growth potential in the End Stage Renal Disease (ESRD) Drug market?

North America was the largest region in the end stage renal disease (ESRD) drug market in 2025. The regions covered in the end stage renal disease (esrd) drug market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.